Factors and causes of cervical cancer (literature review)
https://doi.org/10.58708/2074-2088.2025-1(33)-38-46
Abstract
The article discusses the factors of cervical cancer. Of course, the main role belongs to the human papillomavirus of high carcinogenic risk. However, there is evidence from the authors that 5-7 % of cervical cancer is HPV-negative. In this regard, the review presents non-viral co-factors of the occurrence of cervical cancer. These factors include: the state of the microbiota of the vaginal biotope, the functions of the resident vaginal microflora, and the state of local vaginal immunity. It has been shown that changes in the quantitative composition of the vaginal microbiota occur in cervical cancer, and dysplastic processes are preceded by chronic inflammation and dysregulation of the immune response.
About the Authors
O. P. Lohinava
State Institution "Russian Scientific Research Center for Radiation Medicine and Human Ecology"
Belarus
Belarus
Gomel
N. I. Shevchenko
State Institution "Russian Scientific Research Center for Radiation Medicine and Human Ecology"
Belarus
Belarus
Gomel
E. L. Gasich
State Institution "RC of Hygiene, Epidemiology and Public Health"
Belarus
Belarus
Gomel
References
1. Sung H Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries/ H. Sung [et al.] // CA Cancer J Clin. 2021. 71(3): 209-249. doi: 10.3322/caac.21660.
2. Karpova JuV, Vershinina MG, Kudrjavceva LV. Cervical cancer: the current state of the problem [Rak shejki matki: sovremennoe sostojanie problemy]. Laboratory Service [Laboratornaja sluzhba]. 2012;1:24-35 (Russian).
3. Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical Cancer Screening: A Review. JAMA. 2023;330(6):547–558. doi:10.1001/jama.2023.13174.
4. Barchuk A, Bespalov A, Huhtala H, et al. Breast and cervical cancer incidence and mortality trends in Russia 1980-2013. Cancer Epidemiol. 2018;55:73-80. doi:10.1016/j.canep.2018.05.008.
5. Belyakovskiy VN, Voropayev EV, Volchenko AN, Stasenkova SV. The epidemiological features of genital human papillomavirus infection and cervical cancer in the republic of Belarus and Gomel region (1995-2014) [Jepidemiologicheskie aspekty genital'noj papillomavirusnoj infekcii i raka shejki matki v Respublike Belarus' i Gomel'skoj oblasti (1995–2014 gg.)] Medical news [Medicinskie novosti]. 2016;(7):61-66. (Russian).
6. Loginova OP, Shevchenko NI, Vejalkin IV, Gasich EL Epidemiological aspects of the prevalence of cervical cancer in the Gomel region [Jepidemiologicheskie aspekty rasprostranennosti raka shejki matki v Gomel'skoj oblasti] Health and environment[Zdorov'e i okruzhajushhaja sreda]. 2024;(34):340-346(Russian).
7. . Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;384(2):260-265. doi:10.1016/j.virol.2008.11.046
8. Gheit T (2019) Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology. Front. Oncol. 9:355. doi.org/10.3389/fonc.2019.00355.
9. McBride AA. Oncogenic human papillomaviruses. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160273. doi:10.1098/rstb.2016.0273.
10. Pal A, Kundu R. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol. 2020;10:3116. Published 2020 Jan 21. doi:10.3389/fmicb.2019.03116.
11. Gilham C, Sargent A, Kitchener HC, Peto J. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Health Technol Assess. 2019;23(28):1-44. doi:10.3310/hta23280.
12. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):123-137. doi:10.1093/aje/kwn036.
13. Hudelist G, Manavi M, Pischinger KI, et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol. 2004;92(3):873-880. doi:10.1016/j.ygyno.2003.11.035.
14. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004;64(11):3878-3884. doi:10.1158/0008-5472.CAN-04-0009.
15. Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends Microbiol. 2018;26(2):158-168. doi:10.1016/j.tim.2017.07.007.
16. Catalán-Castorena, Oscar The role of HR-HPV integration in the progression of premalignant lesions into different cancer types. Heliyon, 2024. - Volume 10, Issue 15, e34999.
17. Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV [published correction appears in Lancet Glob Health. 2021 Feb;9(2):e119. doi: 10.1016/S2214-109X(20)30509-X]. Lancet Glob Health. 2021;9(2):e161-e169. doi:10.1016/S2214-109X(20)30459-9.
18. Jin R. et al. The prevalence and genotype distribution of human papilloma virus in cervical squamous intraepithelial lesion and squamous cell carcinoma in Taizhou, China // Medicine. – 2021. – Т. 100. – №. 28. – С. e26593.
19. Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis. 2009;9:191. Published 2009 Nov 30. doi:10.1186/1471-2334-9-191.
20. Вакцины против вируса папилломы человека. Документ по позиции ВОЗ. [Human papillomavirus vaccines WHO position paper. (In Russ).] Wkly Epidemiol Rec. 2009;84(15):117-132.
21. Lee JE, Chung Y, Rhee S, Kim TH. Untold story of human cervical cancers: HPV-negative cervical cancer. BMB Rep. 2022 Sep;55(9):429-438. doi: 10.5483/BMBRep.2022.55.9.042. PMID: 35725012; PMCID: PMC9537028.
22. Tjalma WA, Trinh XB, Rosenlund M, Makar AP, Kridelka F, Rosillon D, Van Dam PA, Collas De Souza S, Holl K, Simon P, Jenkins D. A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium. Facts Views Vis Obgyn. 2015;7(2):101-8. PMID: 26175888; PMCID: PMC4498167.
23. Cancer Genome Atlas Research Network; Albert Einstein College of Medicine; Analytical Biological Services; Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378-384. doi:10.1038/nature21386.
24. WHO Classification of Tumours Editorial Board . Female Genital Tumours. 5th ed. Volume 4 WHO Classification of Tumours; Geneva, Switzerland: 2020.
25. Nicolás I, Marimon L, Barnadas E, et al. HPV-negative tumors of the uterine cervix. Mod Pathol. 2019;32(8):1189-1196. doi:10.1038/s41379-019-0249-1.
26. Tao X, Zheng B, Yin F, et al. Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results. Am J Clin Pathol. 2017;147(5):477-483. doi:10.1093/ajcp/aqx027.
27. Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5(5):CD009069. Published 2018 May 9. doi:10.1002/14651858.CD009069.pub3.
28. Yoshida H, Shiraishi K, Kato T. Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers. Cancers (Basel). 2021 Dec 17;13(24):6351. doi: 10.3390/cancers13246351. PMID: 34944973; PMCID: PMC8699825.
29. Schaff Z., Járay B. Screening for cervical cancer, human papillomavirus (HPV) vaccination. Magy Onkology. 2022. Vol. 31. No 66(4). P. 325-330.
30. Fofanova IY. Possibilities of regulation of the vaginal microflora [Vozmozhnosti reguljacii mikroflory vlagalishha]. Pharmateca [Farmateka]. 2011;12:71-74 (Russian).
31. Drozhdina MB Vaginal microbiota, immune response and some sexually transmitted infections: mechanisms of interaction and regulation of the vaginal ecosystem [Vlagalishhnaja mikrobiota, immunnyj otvet i nekotorye infekcii, peredavaemye polovym putem: mehanizmy vzaimodejstvija i reguljacii vlagalishhnoj jekosistemy]. Clinical dermatology and venereology [Klinicheskaja dermatologija i venerologija]. 2020;19(6):926-933 (Russian).
32. Glushanova NA. Biological properties of lactobacilli [Biologicheskie svojstva laktobacill]. Bulletin of Siberian medicine [Bjulleten' sibirskoj mediciny]. 2003;4:50-58(Russian).
33. Huang, Roujie, et al. "Cervicovaginal Microbiome, High-risk HPV Infection and Cervical Cancer: Mechanisms and Therapeutic Potential." Microbiological Research, vol. 287, 2024, p. 127857.
34. Trubnikova LI, Voznesenskaya NV, Kozhemyatova IV. Secretion of sIgA in cervical mucus in women with background diseases of the cervix [Sekrecija sIgA v cervikal'noj slizi u zhenshhin s fonovymi zabolevanijami shejki matki. Medical almanac [Medicinskij al'manah]. 2009;4:134-136.
35. Molina MA, Steenbergen RDM, Pumpe A, Kenyon AN, Melchers WJG. HPV integration and cervical cancer: a failed evolutionary viral trait. Trends Mol Med. 2024;30(9):890-902.doi:10.1016/j.molmed.2024.05.009.
Supplementary files
Review
For citations:
Lohinava O.P., Shevchenko N.I., Gasich E.L. Factors and causes of cervical cancer (literature review). Medical and Biological Problems of Life Activity. 2025;(1):38-46. (In Russ.) https://doi.org/10.58708/2074-2088.2025-1(33)-38-46
Views:
36
Email this article 